Nebraska Hematology-Oncology, P.C. — Lincoln, Nebraska

Nebraska Hematology-Oncology, P.C. is a clinical research site located in Lincoln, Nebraska, United States 68506.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Nebraska Hematology-Oncology, P.C. has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Triple Negative Breast Cancer, Breast Cancer, Primary Myelofibrosis.

Sponsors: G1 Therapeutics, Inc., CTI BioPharma, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Hematology-Oncology, P.C.?

Nebraska Hematology-Oncology, P.C. has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Hematology-Oncology, P.C. conducted?

Nebraska Hematology-Oncology, P.C. has 5 clinical trials on record, with 1 currently active. Their work covers Triple Negative Breast Cancer, Breast Cancer, Primary Myelofibrosis.

Is Nebraska Hematology-Oncology, P.C. accredited by Crixeo Health?

Yes — Nebraska Hematology-Oncology, P.C. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Nebraska Hematology-Oncology, P.C.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.